VERO Venus Concept

Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference, which is being held virtually and in person at the Lotte New York Palace in New York, NY from September 11th-13th.

Management’s presentation will be available on demand beginning on Monday, September 11th at 7:00 a.m. Eastern Time. Management will participate in investor meetings on Tuesday, September 12th.

An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at . An archive of the webcast will be available for replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 14 direct markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.



Investor Relations Contact:

ICR Westwicke on behalf of Venus Concept:

Mike Piccinino, CFA
EN
06/09/2023

Underlying

VEROVenus Concept

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Venus Concept

 PRESS RELEASE
Free
VERO VENUS CONCEPT

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial ...

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025 TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2025 financial results will be released after the market closes on Thursday, August 14, 2025. Management will host a conference call at 5:00 p.m. Eastern Time on August 14, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to partici...

July 16, 2025 1 EN
 PRESS RELEASE
Free
VERO VENUS CONCEPT

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transacti...

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction Further reduction of outstanding debt by Madryn Asset Management improves the Company’s balance sheet position TORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company exchanged $6.5 million of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP (“Madryn”) for 325,651 shares of its Series Y preferred stock. Following the transactio...

July 1, 2025 1 EN
 PRESS RELEASE
Free
VERO VENUS CONCEPT

Venus Concept Announces Closing of Up To $3.45 Million Registered Dire...

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of ...

June 9, 2025 1 EN
 PRESS RELEASE
Free
VERO VENUS CONCEPT

Venus Concept Announces Up To $3.45 Million Registered Direct Offering...

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 434,720 shares of common stock at a purchase price of $2.65 per share i...

June 6, 2025 1 EN
 PRESS RELEASE
Free
VERO VENUS CONCEPT

Venus Concept Announces Definitive Agreement to Sell Venus Hair Busine...

Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG Co. Ltd (“Meta Healthcare Group”) in an all-cash transaction valued at $20 million, subject to a customary working capital adjustment. The net proceeds from the transaction, once completed, will enhance the Company’s balance sheet and financial cond...

June 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch